ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1507

Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis Patients: The Frequency and Associated Disease Features

Fabian Dario Sinigaglia1, Rafael Chaparro del Moral1, Silvia Papasidero1, Oscar Luis Rillo1, José Angel Caracciolo2, María Alejandra Medina1, Analia Dellepiane3, Cecilia Zaffarana4, Maria de los Angeles Correa5, Luciana Casalla6, Lucía Zarate6, Nieves Capozzi7, María Victoria Martire8, Marta Mamani8, Damaris Alvarez9, Eduardo Kerzberg9 and José Luis Velasco Zamora10, 1Rheumatology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 2Rhematology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 3CEMEC, Santa Fe, Argentina, 4Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 6Rheumatology Section, Hospital Posadas, Buenos Aires, Argentina, 7'Irigoyen 1418. CABA, Hospital Posadas, Buenos Aires, Argentina, 8Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 9Rheumatology Section, Hospital General de Agudos Dr. J. M. Ramos Mejía, Buenos Aires, Argentina, 10Reumatología al Sur, Berazategui, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Rheumatoid arthritis (RA) and sleep apnea

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Obstructive Sleep Apnea Syndrome (OSA) affects 2-4% of the population and it has been observed in rheumatoid arthritis (RA) patients in up to 30.8%. Besides, OSA has been determined as an independent risk factor for arterial hypertension (AHT) and has been associated with cardiovascular disease and stroke. There is little information in the literature about the relationship between this syndrome and the characteristics of RA, therefore the aim of this study is to investigate the risk of OSA in patients with RA and related factors.

Methods: We conducted a multicenter cross-sectional observational study that included consecutive RA patients (ACR 1987-ACR/EULAR 2010). Socioeconomic status, clinical data and comorbidities were recorded. OSA risk was assessed by the Berlin Sleep Apnea Questionnaire and daytime sleepiness by the Epworth Sleepiness Scale. Visual Analog Scale for pain (VAS pain), RAPID3, DAS28, HAQ-DI and Hospital Anxiety and Depression Scale (HADS A and HADS D) were also assessed. For data analysis descriptive statistics, X2test, T-Test and binary logistic regression for multivariate analysis were applied, using OSA risk as dependent variable.

Results: Of 168 RA patients, OSA high risk was observed in 71 patients (42%) and daytime sleepiness in 50 patients (29.7%). Patients with high OSA risk showed higher BMI (29 ± 5 vs 26 ± 5, p <0.001), higher disease activity [DAS28 (4.5 ± 1.4 vs 3.7 ± 1.2, p <0.001) and RAPID3 (14 ± 7 vs 10 ± 6, p <0.002)], and worse functional capacity [HAQ (1.3 ± 0.7 vs 0.9 ± 0.7, p <0.01)]. The frequency of AHT was higher among patients with high OSA risk (42% vs 19%, p <0.002), as well as with daytime sleepiness (43% vs 25%, p <0.02), anxiety and depression disorders [HAD-A (9.2±4 vs 6.5 ± 4, p<0.001) and HAD-D (7.5±3 vs 5.4 ± 3, p<0.001)] than the low OSA risk group. In multivariate anaIysis, the independently variables associated with high OSA risk were BMI (OR 1.14, 95%CI: 1.052-1.235, p = 0.001) and DAS28 (OR 1.13, 95%CI: 1.006-2.459, p = 0.047).

Conclusion:

The risk of OSA was 42% in patients with RA and was associated with BMI and disease activity.


Disclosure: F. D. Sinigaglia, None; R. Chaparro del Moral, None; S. Papasidero, None; O. L. Rillo, None; J. A. Caracciolo, None; M. A. Medina, None; A. Dellepiane, None; C. Zaffarana, None; M. D. L. A. Correa, None; L. Casalla, None; L. Zarate, None; N. Capozzi, None; M. V. Martire, None; M. Mamani, None; D. Alvarez, None; E. Kerzberg, None; J. L. Velasco Zamora, None.

To cite this abstract in AMA style:

Sinigaglia FD, Chaparro del Moral R, Papasidero S, Rillo OL, Caracciolo JA, Medina MA, Dellepiane A, Zaffarana C, Correa MDLA, Casalla L, Zarate L, Capozzi N, Martire MV, Mamani M, Alvarez D, Kerzberg E, Velasco Zamora JL. Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis Patients: The Frequency and Associated Disease Features [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/risk-of-obstructive-sleep-apnea-in-rheumatoid-arthritis-patients-the-frequency-and-associated-disease-features/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-obstructive-sleep-apnea-in-rheumatoid-arthritis-patients-the-frequency-and-associated-disease-features/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology